Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells
- Department of Biochemistry and Molecular Biology, Medical College of Shantou University, Shantou 515041 (China)
- College of Life Science and Biological Engineering, Beijing University of Technology, Beijing 100022 (China)
- Department of Pathology, Medical College of Shantou University, Shantou 515041 (China)
- Department of Experimental Animal Center, Medical College of Shantou University, Shantou 515041 (China)
Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility in various transformed cells. The overexpression of fascin in esophageal squamous cell carcinoma (ESCC) has been described only recently, but the roles and mechanism still remained unclear. Here, by using RNA interference (RNAi), we have stably silenced the expression of the fascin in EC109 cells, an ESCC cell line. Down-regulation of fascin resulted in a suppression of cell proliferation and as well as a decrease in cell invasiveness. Furthermore, we revealed that fascin might have functions in regulating tumor growth in vivo. The effect of fascin on cell invasiveness correlated with the activation of matrix metalloproteases such as MMP-2 and MMP-9. We examined that fascin down-expression also led to a decrease of c-erbB-2 and {beta}-catenin at the protein level. These results suggested that fascin might play crucial roles in regulating neoplasm progression of ESCC.
- OSTI ID:
- 20713437
- Journal Information:
- Biochemical and Biophysical Research Communications, Vol. 337, Issue 1; Other Information: DOI: 10.1016/j.bbrc.2005.09.055; PII: S0006-291X(05)02056-5; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma
c-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinoma